← Leaderboards
Mary Eapen
Medical College Of Wisconsin
$20,614,610
Attributed
$41,229,220
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $21.4M · FY2015–25$25M$18.8M$12.5M$6.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,229,220 · 5
By mechanism
OT3$32,852,194 · 1
R01$4,780,411 · 1
R38$1,852,150 · 2
U01$1,744,465 · 1
Top collaborators
- Michael E Widlansky7 shared
- Mary M Horowitz6 shared
- Adam M. Mendizabal5 shared
- David Allen Wilcox3 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David Allen Wilcox$6,145,617
- Michael E Widlansky$10,705,548
- David D. Gutterman$10,700,543
- Jay Neitz$14,385,238
- Mary M Horowitz$184,978,306
Others in their field
Top investigators on “National Heart, Lung, And Blood Institute”
- Sonia M Thomas · Research Triangle Institute$703,479,505
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$86,090,843
Research focus
National Heart, Lung, And Blood InstituteInnovationResearch PersonnelDesignWisconsinLearningHematologyFundingMedical SchoolsSickle Cell AnemiaSuccessCollaborationsBloodSickle CellResourcesEnsureGene TherapyLeadTransplantationRecruitMeetingsInternational CenterMaintenanceFaculty
Grant awards (21)
Medical College of Wisconsin Physician Scientist Immersion Program$192,924
R38 · FY2025 · HL
Medical College of Wisconsin Physician Scientist Immersion Program$368,035
R38 · FY2024 · HL
Cure Sickle Cell$352,315
OT3 · FY2024 · HL · contact PI
Cure Sickle Cell$13,557,758
OT3 · FY2023 · HL · contact PI
Cure Sickle Cell$3,729,772
OT3 · FY2023 · HL · contact PI
Cure Sickle Cell$2,340,191
OT3 · FY2023 · HL · contact PI
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies$1,577,015
R01 · FY2023 · HL
Medical College of Wisconsin Physician Scientist Immersion Program$195,119
R38 · FY2023 · HL
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies$1,589,707
R01 · FY2022 · HL
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies$1,613,689
R01 · FY2021 · HL
Stimulating Access to Research in Residency (StARR)$274,018
R38 · FY2021 · HL
Cure Sickle Cell$9,872,158
OT3 · FY2020 · HL
Stimulating Access to Research in Residency (StARR)$274,018
R38 · FY2020 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC$370,715
U01 · FY2019 · HL · contact PI
Stimulating Access to Research in Residency (StARR)$274,018
R38 · FY2019 · HL
Cure Sickle Cell$3,000,000
OT3 · FY2018 · HL · contact PI
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC$360,752
U01 · FY2018 · HL · contact PI
Stimulating Access to Research in Residency (StARR)$274,018
R38 · FY2018 · HL
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC$361,056
U01 · FY2017 · HL · contact PI
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC$294,286
U01 · FY2016 · HL · contact PI
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC$357,656
U01 · FY2015 · HL · contact PI